Asaka, M., Sugiyama, T., Nobuta, A., Kato, M., Takeda, H. and Graham, D.Y. (2001) Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter6: 294-299.
2.
Blaser, M.J. (1999) Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis179: 1523-1530.
3.
Chen, L.T., Lin, J.T., Tai, J.J., Chen, G.H., Yeh, H.Z., Yang, S.S. et al. (2005) Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst97: 1345-1353.
4.
Chen, Y. and Blaser, M.J. (2007) Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med167: 821-827.
5.
Chen, Y. and Blaser, M.J. (2008) Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis198: 553-560.
6.
Chey, C.D. and Wong, B.C. (2007) American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol102: 1808-1825.
7.
Chiba, N., Van Zanten, S.J., Sinclair, P., Ferguson, R.A., Escobedo, S. and Grace, E. (2002) Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult randomized controlled trial. BMJ324: 1012-1016.
8.
Cremonini, F., Di Caro, S., Delgado-Aros, S., Supulveda, A., Gasbarrini, G., Gasbarrini, A. et al. (2003) Meta-analysis: the relationship between Helicobacter pylori infection and gastro-esophageal reflux disease. Aliment Pharmacol Ther18: 279-289.
9.
DuBois, S. and Kearney, D.J. (2005) Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. Am J Gastroenterol100: 453-459.
10.
Eslick, G.D., Lim, L.L., Byles, J.E., Xia, H.H. and Talley, N.J. (1999) Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol94: 2373-2379.
11.
EUROGAST Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet341: 1359-1362.
12.
Fischbach, W., Goebeler-Kolve, M.E., Dragosics, B., Greiner, A., Stolte, M. et al. (2004) Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut53: 34-37.
13.
Fock, K.M., Talley, N.J., Moayyedi, P., Hunt, R., Azuma, T., Sugano, K. et al. (2008) Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol23: 351-365.
14.
Ford, A.C., Delaney, B.C., Forman, D. and Moayyedi, P. (2004) Eradication therapy in Helicobacter pylori positive peptic ulcer disease: Systematic review and economic analysis. Am J Gastroenterol99: 1833-1855.
15.
Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S. et al. (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet372: 392-397.
16.
Gasbarrini, A., Franceschi, F., Tartaglione, R., Landolfi, R., Pola, P. and Gasbarrinin, G. (1998) Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet352: 878.
17.
Graham, D.Y., Yamaoka, Y. and Malaty, H.M. (2007) Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Helicobacter12S2: 64-68.
18.
Graham, D.Y. and Shiotani, A. (2008) New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol5: 321-331.
19.
Hsu, P.I., Lai, K.H., Tseng, H.H., Lo, G.H., Lo, C.C., Lin, C.K. et al. (2001) Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther15: 195-201.
20.
Hu, F.L., Hu, P.J. and Liu, W.Z. (2008) Third Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis9: 178-184.
21.
Huang, J.Q., Sridhar, S., Chen, Y. and Hunt, R.H. (1998) Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology114: 1169-1179.
22.
Huang, J.Q., Sridhar, S. and Hunt, R.H. (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet359: 14-22.
23.
Huang, J.Q., Zheng, G.F., Sumanac, K., Irvine, E.J. and Hunt, R.H. (2003) Meta-analysis of the relationship between Cag A seropositivity and gastric cancer. Gastroenterology125: 1636-1644.
24.
Hunt, R.H., Sumanac, K. and Huang, J.Q. (2001) Review article: should we kill or should we save Helicobacter pylori? Aliment Pharmacol Ther15(Suppl. 1): 51-59.
25.
International Agency for Research on Cancer ( 1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans, Lyon, 7-14 . IARC Monogr Eval Carcinog Risks Hum61: 1-241.
26.
Kuipers, E.J., Klinkenberg-Knol, E.C., Vandenbroucke-Grauls, C.M., Appelmelk, B.J., Scehenk, B.E. and Meuwissen, S.G. (1997) Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol223: 28-34.
27.
Laine, L. and Sugg, J. (2002) Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol97: 2992-2997.
28.
Leodolter, A., Kulig, M., Brasch, H., Meyer-Sabellek, W., Willich, S.N. and Malfertheiner, P. (2001) A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther15: 1949-1958.
29.
Linz, B., Balloux, F., Moodley, Y., Manica, A., Liu, H., Roumagnac, P. et al. (2007) An African origin for the intimate association between humans and Helicobacter pylori. Nature445: 915-918.
30.
Liu, C.C., Lee, C.L., Chan, C.C., Tu, T.C., Liao, C.C., Wu, C.H. et al. (2003) Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer. Arch Intern Med163: 2020-2024.
31.
McColl, K., Murray, L., El-Omar, E., Dickson, A., El-Nujumi, A., Wirz, A. et al. (1998) Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med339: 1869-1874.
32.
McNamara, D., Buckley, M., Gilvarry, J., O'Morain, C. et al. (2002) Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: A 5-year follow-up study. Helicobacter7: 317-321.
33.
Mahadeva, S., Chia, Y.C., Vinothini, A., Mohazmi, M. and Goh, K.L. (2008) Cost effectiveness and satisfaction of a Helicobacter pylori `test and treat' strategy compared to prompt endoscopy in young Asian dyspeptics. Gut57: 1214-1220.
34.
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D. et al. (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut56: 772-781.
35.
Marshall, B.J. and Warren, J.R. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet1: 1311-1315.
36.
Marshall, B.J. (1994) Helicobacter pylori. Am J Gastroenterol89: S116-128.
37.
Metz, D.C. and Kroser, J.A. (1999) Helicobacter pylori and gastroesophageal reflux disease. Gastroenterol Clin North Am28: 971-985.
38.
Nakajima, S. and Hattori, T. (2004) Esophageal adenocarcinoma or gastric cancer with or without eradication of Helicobacter pylori infection in chronic atrophic gastritis patients: a hypothetical opinion from a systematic review. Aliment Pharmacol Ther20(Suppl. 1): 54-61.
39.
Ohkuma, K., Okada, M., Murayama, H., Seo, M., Maeda, K., Kanda, M. et al. (2000) Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol15: 1105-1112.
40.
Papatheodoridis, G.V. and Archimandritis, A.J. (2005) Role of Helicobacter pylori eradication in aspirin on non-steroidal anti-inflammatory drug users . World J Gastroenterol11: 3811-3816.
41.
Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A.B., Warnke, R.A., Jellum, E. et al. (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med330: 1267-1271.
42.
Romano, M., Iovene, M.R., Russo, M.I., Rocco, A., Salerno, R., Cozzolino, D. et al. (2008) Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J Clin Pathol61: 1112-1115.
43.
Schwizer, W., Thumshirn, M., Dent, J., Guldenschuh, I., Menne, D., Cathomas, G. et al. (2001) Helicobacter pylori and symptomatic relapse of gastro-esophageal reflux disease: a randomized controlled trial. Lancet357: 1738-1742.
44.
Sharma, V.K., Sahai, A.V., Corder, F.A. and Howden, C.W. (2001) Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther15: 1939-1947.
45.
Shirota, T., Kusano, M., Kawamura, O., Horikoshi, T., Mori, M., Sekiguchi, T. et al. (1999) Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol34: 553-559.
46.
Singh, K. and Ghoshal, U.C. (2006) Causal role of Helicobacter pylori infection in gastic cancer: an Asian enigma. World J Gastroenterol12: 1345-1351.
47.
Siurala, M., Lehtola, J. and Ihamaki, T. (1974) Atrophic gastritis and its sequelae. Results of 19-23 years' follow-up examinations. Scand J Gastroenterol9: 441-446.
48.
Siurala, M., Varis, K. and Wiljasalo, M. (1966) Studies of patients with atrophic gastritis: a 10-15-year follow-up. Scand J Gastroenterol40-8.
49.
Talley, N.J., Fock, K.M. and Moayyedi, P. (2008) Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol103: 510-514.
50.
Tefera, S., Hatlebakk, J.G. and Berstad, A. (1999) The effect of Helicobacter pylori eradication on gastro-esophageal reflux. Aliment Pharmacol Ther13: 915-929.
51.
Tsutsumi, Y., Kanamori, H., Yamato, H., Ehira, N., Kawamura, T., Umehara, S. et al. (2005) Randomized study of H. pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. Ann Hematol84: 807-811.
52.
Vergara, M., Catalan, M., Gisbert, J.P. and Calvet, X. (2005) Meta-analaysis: Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther21: 1411-1418.
53.
Watanabe, T., Tada, M., Nagai, H., Sasaki, S. and Nakao, M. (1998) Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology115: 642-648.
54.
Weston, A.P., Badr, A.S., Topalovski, M., Topalovski, M., Cherian, R., Dixon, A. et al. (2000) Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol95: 387-394.
55.
Wong, B.C., Lam, S.K., Wong, W.M., Chen, J.S., Zheng, T.T., Teng, R.E. et al. (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial . JAMA291: 187-194.
56.
Wotherspoon, A.C., Ortiz-Hidalgo, C., Falzon, M.R. and Issacson, P.G. (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet338: 1175-1176.
57.
Zhou, L., Sung, J.J., Lin, S., Jin, Z., Ding, S., Huang, X. et al. (2003) A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chinese Med J116: 11-14.
